Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-088290
Filing Date
2026-03-03
Accepted
2026-03-03 16:23:21
Documents
88
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K anab-20251231.htm   iXBRL 10-K 4274288
2 EX-21.1 anab-ex21_1.htm EX-21.1 4624
3 EX-23.1 anab-ex23_1.htm EX-23.1 3716
4 EX-31.1 anab-ex31_1.htm EX-31.1 15962
5 EX-31.2 anab-ex31_2.htm EX-31.2 15859
6 EX-32.1 anab-ex32_1.htm EX-32.1 8958
7 EX-32.2 anab-ex32_2.htm EX-32.2 8837
8 GRAPHIC img34946322_0.jpg GRAPHIC 61984
  Complete submission text file 0001193125-26-088290.txt   16253661

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT anab-20251231.xsd EX-101.SCH 1586962
91 EXTRACTED XBRL INSTANCE DOCUMENT anab-20251231_htm.xml XML 3603293
Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

EIN.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37985 | Film No.: 26714681
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)